Find Clinical Trials
The advancement of medicine depends upon millions of people who volunteer to participate in clinical studies or trials every year. Participating in research is essential for furthering the understanding of lupus and other diseases and, ultimately, leads to more effective treatments.
If you're wondering how clinical trials work, take a look at our frequently asked questions about participating in clinical trials. This includes the basics of clinical trials, how to get started, what is involved in being a part of a clinical trial and more.
Featured clinical trials
In collaboration with research partners, the Lupus Foundation of America goes to great lengths to educate and raise awareness about the rights of clinical trial volunteers, opportunities to engage in research, and the importance of clinical trial participation. Learn more about some of the lupus trials currently enrolling.
The purpose of this study is to establish the tolerability, preliminary efficacy, and pharmacokinetics of CC-97540 in participants with severe, refractory systemic lupus erythematosus (srSLE). Patients with srSLE have a type of lupus that does not go into remission despite receiving appropriate therapies.
The purpose of this study is to establish the safety and potential effectiveness of investigational FT819 in participants with moderate to severe systemic lupus erythematosus (SLE) with or without lupus nephritis (lupus-related kidney disease, LN).
Are you between the ages of 18-70? Have you been diagnosed with systemic lupus erythematosus (SLE) for at least 6 months? The APATURA study is evaluating an investigational medication in SLE patients who are currently taking medications for SLE and still experience SLE symptoms.
In this clinical trial, researchers are studying the T cell engager, CLN-978, as a potential treatment for people with active moderate to severe systemic lupus erythematosus (SLE) and have not responded well to at least two previous treatments.
The purpose of this study is to evaluate the safety and efficacy of CNTY-101, an investigational “off-the-shelf” CAR NK-cell therapy, in participants with refractory B cell-mediated autoimmune diseases, including those with moderate to severe systemic lupus erythematosus (SLE) and lupus nephritis (LN, lupus-related kidney disease).
As many as half of all adults living with lupus have kidney disease related to their lupus. This condition, called lupus nephritis, can worsen over time and may lead to kidney failure. Studies like the Ntrust-1 study are designed to assess the safety and activity of a new investigational therapy.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
Search for clinical trials
Antidote provides a services that allows you to search for clinical trials based on both your location and your specific condition.
Know your options | Access the latest treatments | Receive world-class care
About Antidote: Antidote delivers clear, unbiased information about clinical trial options. We aim to match you to the best trial, regardless of sponsor. Find Antidote's privacy policy here.
Other ways to find clinical trials
Search these sites to find information about clinical trials near you.
- ClinicalTrials.gov - a registry of both publicly and privately supported clinical studies maintained by the US National Institutes of Health.
- CenterWatch.com - the largest online listing of industry-sponsored global clinical trials.
RAY: Research Accelerated by You is a lupus data platform where people with lupus and caregiversprovide information about their lupus experience. Help brighten the future of lupus research.